Stanford University Medical Center
Dr. Joel Neal, MD, PhD, Associate Professor of Medicine (Oncology), maintains an active thoracic medical oncology practice, designs and conducts clinical trials, and facilitates translational research collaborations. His clinical trials expertise includes overcoming acquired resistance to targeted therapies, understanding and improving the efficacy of immunotherapy, and applying circulating tumor DNA technology to inform treatment decisions. He has published dozens of articles in the field of thoracic oncology, including in Lancet Oncology, Nature Medicine, and the Journal of Clinical Oncology. He leads the Stanford Thoracic Clinical Research Group and improves the Stanford cancer clinical research enterprise as medical director of the Cancer Clinical Trials Office. As IT Medical Director of the Stanford Cancer Center, he maintains and enhances the EPIC electronic health record to benefit providers and patients, and effects change through the NCCN EHR Oncology Advisory Group. He serves as study chair and thoracic core committee member in the ECOG-ACRIN cooperative group, is an active participant within the American Society of Clinical Oncology (ASCO), and contributes to the CME and Education committees within the International Association of the Study of Lung Cancer (IALSC). He has presented worldwide to educate clinicians and researchers.
AbbVie (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Adaptimmune (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Amgen (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; ASCO COI website: https://coi.asco.org/share/BT7-A83P/Joel%20Neal, https://coi.asco.org/share/BT7-A83P/Joel%20Neal, Other Financial or Material Support, Other Financial or Material Support; AstraZeneca (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Biomedical Learning Institute CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Blueprint Pharmaceuticals (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Boehringer Ingelheim (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Calithera Biosciences (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Clinical Care Options CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; CME Matters (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; D2G Oncology (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Eli Lilly & Company (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Exelixis (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant, Grant/Research Support, Grant/Research Support; GSK (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; HMP Education (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Iovance Biotherapeutics (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Janssen (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Jounce Therapeutics (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Medical Educator Consortium (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Medscape CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Merck (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Mirati Therapeutics (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; MJH Life Sciences CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; MLI Peerview CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Natera (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Nektar Therapeutics (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Novartis (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Prime Oncology CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Projects in Knowledge CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Regeneron Pharmaceuticals (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Research to Practice CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Roche/ Genentech (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant, Grant/Research Support, Grant/Research Support; Rockpointe CME (Individual(s) Involved: Self): Honoraria, Honoraria, Other Financial or Material Support, Other Financial or Material Support; Sanofi/Regeneron (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Surface Oncology (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant; Takeda Pharmaceuticals U.S.A. (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant, Grant/Research Support, Grant/Research Support; Turning Point Therapeutics (Individual(s) Involved: Self): Advisory Board, Advisory Board, Consultant, Consultant
Wednesday, August 24, 2022
8:55 AM – 10:45 AM
Wednesday, August 24, 2022
10:00 AM – 10:15 AM
Wednesday, August 24, 2022
10:25 AM – 10:45 AM
Thursday, August 25, 2022
1:35 PM – 3:30 PM
Thursday, August 25, 2022
2:27 PM – 2:34 PM
Thursday, August 25, 2022
2:34 PM – 2:40 PM
Thursday, August 25, 2022
3:10 PM – 3:30 PM
Wednesday, November 9, 2022
9:00 AM – 10:45 AM
Wednesday, November 9, 2022
9:55 AM – 10:10 AM
Wednesday, November 9, 2022
10:20 AM – 10:45 AM
Friday, November 11, 2022
9:00 AM – 11:00 AM
Friday, November 11, 2022
10:22 AM – 10:29 AM
Friday, November 11, 2022
10:29 AM – 10:35 AM
Friday, November 11, 2022
10:35 AM – 11:00 AM